Product

Benralizumab-exposure

1 clinical trial

1 indication

Indication
Asthma
Clinical trial
The Benralizumab Pregnancy Exposure Study: A VAMPSS Post Marketing Surveillance Study
Status: Terminated, Estimated PCD: 2023-12-29